Purine metabolism and phosphoribosylpyrophosphate content of lymphocytes and erythrocytes were studied in an immunocompetent black male child with a total deficiency of erythrocyte and partial deficiency of lymphocyte adenosine deaminase. The partial genetic deficiency of adenosine deaminase was demonstrated in intact lymphocytes, and was approximately one third of the deaminating activity of control lymphocytes. Intact lymphocytes of the patient did not incorporate adenosine a t a faster rate than those of control lymphocytes. The patient's erythrocytes deaminating activity was low and adenine ribonucleotide synthesis from adenosine was increased several fold, while adenine incorporation into purine ribonucleotides was comparable to that of control erythrocytes. Transfusion with packed erythrocytes temporarily improved the deaminating capacity of circulating erythrocytes, but did not reduce the elevated incorporation of adenosine into purine ribonucleotides.
Summary
Purine metabolism and phosphoribosylpyrophosphate content of lymphocytes and erythrocytes were studied in an immunocompetent black male child with a total deficiency of erythrocyte and partial deficiency of lymphocyte adenosine deaminase. The partial genetic deficiency of adenosine deaminase was demonstrated in intact lymphocytes, and was approximately one third of the deaminating activity of control lymphocytes. Intact lymphocytes of the patient did not incorporate adenosine a t a faster rate than those of control lymphocytes. The patient's erythrocytes deaminating activity was low and adenine ribonucleotide synthesis from adenosine was increased several fold, while adenine incorporation into purine ribonucleotides was comparable to that of control erythrocytes. Transfusion with packed erythrocytes temporarily improved the deaminating capacity of circulating erythrocytes, but did not reduce the elevated incorporation of adenosine into purine ribonucleotides.
Phosphoribosylpyrophosphate content of the patient's lymphocytes and erythrocytes was not diminished. Incubation of erythrocytes with adenosine lowered phosphoribosylpyrophosphate content while incubation with phosphate increased phosphoribosylpyrophosphate content to the same extent in mutant and control erythrocytes.
Speculation
The finding that the patient's lymphocytes can deaminate adenosine to some extent may explain why the rate of adenosine incorporation into purine ribonucleotides of his lymphocytes is not increased and immune function is not impaired. Deficiency of erythrocyte adenosine deaminase results in increased adenosine incorporation, but does not appear to interfere with immune functions.
INTRODUCTION
The discovery that two inborn errors of purine metabolism, adenosine deaminase (ADA) (EC 3.5.4.4) and purine nucleoeide phosphorylase (PNP) (EC 2.4.2.1) deficiency are associated with syndromes of disordered immune function highlights the importance of purine catabolism and salvage in the normal differentiation, proliferation and function of lymphocytes (8.7).
Deficiency of ADA gives rise to severe combined immunodeficiency (SCID), an inherited disorder of T and B cell function, and deficiency of PNP to selective cellular immunodeficiency, an inherited abnormality of T cell function (8.5).
ADA plays an important role in the catabolism and salvage of purines. It catalyses the deamination of adenosine to inosine, which in turn is converted to hypoxanthine by PNP according to the following reactions:
The two enzymes which catalyse consecutive steps in purine breakdown are also essential for the salvage of purines by providing hypoxanthine for ribononucleotide synthesis. Both enzymes play an important and as yet not clearly defined role in the normal immune functions of lymphocytes.
ADA is controlled by a single genetic locus and the enzyme deficiency is transmitted as an autosomal recessive trait from heterozygous patients (9.1, 10,115). While the enzyme deficiency in SCID is clearly present at birth, failure of imune function may develop more gradually and in 15% of the patients the impairment of cellular imunity may initially be more severe than that of h m r a l imunity (10.16).
Phosphoribosylpyrophosphate (PP-Rib-P) is the substrate for the synthesis of phosphoribosyl-1-amine, the first intermediate in +ze purine biosyntheSiS, and also serves as a substrate for the conversion of hypaxanthine to inosinate. It is therefore an important substrate for the synthesis of purine ribonucleotides by the &e and the salvage pathway. A decrease in cellular PP-Rib-P content could interfere with lymphocyte proliferation. It is known that adenosine can lover cellular PP-Rib-P (17.22).
For this reason PPRib-P content of the patient's erythrocytes and lymphocytes was determined during his early development and the effect of adenosine on erythrocyte and lymphocyte PP-Rib-P content studied in vitro.
Genetic heterogeneity is to be expected in a rare autosomal recessive disorder, and to date one African child with complete ADA deficiency in lysates of erythrocytes but partial deficiency in lymphocyte lysates and apparently normal immune function has been described (15) . The present study reports on the biochemical abnormalities in intact lymphocytes and erythrocytes of a black American child with total Erythrocyte and partial lymphocyte ADA deficiency in whom no abnormalities in imune function have been detected during his first two years of life (8.9).
MATERIALS AND METHODS

Case Nstory :
The patient, a black male child was the premature product (8 months gestation) of a non-consanguinousmatinq. At one month of age, ADA deficiency was diagnosed as part of the New York State neonatal screening program and the diagnosis confirmed by quantitative assay of hemolysates. The child was transfused for physiologic anemia at another hospital with 40 ml of packederyihrocytes. After transfer to this hospital no further transfusions have been given and the child has developed normally with no signs of graft versus host reaction. He has displayed normal h-ral and cellular immune function including specific antibody production and mitogenic response to specific antigens (3,121..
Blood samples :
All studies were carried out on freshly drawn heparinized blwd. Erythrocytes were harvested by centrifugation.washed in phosphate-buffered saline (0.9% NaCl in 0.01 M phosphate buffer, pH 7.3) and incubated with the appropriate radioactive tracers. Phosphoribosylpyrophosphate determinations were also carried out on unwashed erythrocytes harvested by brief (1 min) centrifugation, in a microcentrifuge. Lymphocytes were harvested by banding on a Ficoll-Hypaque gradient (Lymphoprep-Nyegaard and Co W S Oslo, nor way)^ these preparations contain not only lymphocytes but also monocytes and platelets. Lymphocytes were washed (3 times) with PBS prior to incubation.
Conditions of incubation of intact cells:
Short term incubations (20 to 90 min) were carried out in air under gentle shaking in a water bath at 37%. Longer incubations were done in an incubator in an atmosphere of 58 C02and 95% air.
ADA determinations in cell lysates:
These were carried out by a modification of the method used by Hopkinson et al. (14) . Hermlysates and lymphocyte lysates were prepared and assayed as previously described at 1.3 rn adenosine (11.13). Briefly, the assay (14) is based on two linked reactions, the inosine produced is converted tohypoxanthine by the action of endogenous nucleoside phosphorylase present in the hemolysates, or by adding the enzyme to lymphocyte lysates. Hypaxanthine is oxidized to uric acid by including xanthine oxidase in the reaction mixture.
A more direct assay of ADA measured the deamination of [8-14cl adenosine. For this assay hemolysates were diluted in 0.01 M Tris-HC1 buffer pH 7.5 (1:81 times for control, 1:10 times for ADA-samples). Hermlysates (25 Vl) were incubated with [a-14c1 adenosine (.09.iN) in 0.2 ml 50 mM Tris-HC1 EETA buffer pH 7.5. Incubations were carried out for 30 to 120 min in the presence and absence of 50 pH erythro-5-2-hydroxy-3-nonyl adenine (EHNA). Reactions were terminated by the addition of ice cold perchloric acid; after centrifugation at 4' the supernatant fraction was neutralized with KOH and the precipitate removed by centrifugation. Adenosine was separated from hypoxanthine, inosine and adenine by paper chromatography on Whatman DE 81 paper developed in 1 mH a m n i u m formate (6) . Radioactivity was counted in toluene containing 2.5 diphenyloxarole and p-bis 2-(5 phenyloxazolyl) benzene (PPO and POPOP) in a BecloMn liquid scintillation counter. Values are reported as EHNA inhibitable activity. The assay is linear with time and concentration of cell lysates.
tides of intact cells:
Following incubation cells were harvested by centrifugation at 600 x g, all pellets were extracted with 600 y 1 2N perchloric acid, supernatant fractions were neutralized with KOH and aliquots of the supernatant fractions applied to formate washed plastic backed polyethyleneimine thin layer plates (Macheray Nagel and Co. distributed by Brinkman). Plates were developed stepwise in m n i u m formate (7), or lithium chloride (19).
Adenosine metabolites in the media "ere identified by thin layer chrormtography on polyethyleneimine plates which were developed in 1-butanol, methanol, water and anmanium hydroxide (60:20:20:1).
Radioactivity was counted in toluene (5g PPO per liter) in a Beckman liquid scintillation counter.
PP-Rib-P content was determined in freshly harvested cells as described (23). Briefly 1.4 x lo6 lymphocytes or 10-20 p1 packed erythrocytes were suspended in 300 p1 1 rn potassium phosphate buffer pH 7.3 containing 1 rn EDTA.
Cells were heated for 45 seconds at go0, chilled on ice and centrifuged at 4 ' . The supernatant fractions were incubated with O.2p Ci [7-14c) orotic acid (S.A. 42.2mCi/ml),4 mM MgC12, and 1 mg freshly prepared yeast orotidylate synthetase (P-L Biochemicals Inc) containing orotidylate decarboxylase. 114~0~1 was collected on filters wetted with KOH and counted in toluene diphenyloxazole (59 PPO/l).
Chemicals
Radioactive purin bases, nucleosides and orotic acid were purchased from New England Nuclear, [%-I thymidine (S.A. 1.9 Ci/mM) from Schwarz Mann Co. EHNA Was purchased from Burroughs Wellcome, Triangle Park, s.c. Purine nucleosides and bases were purchased from Calbiochem, tissue culture materials from Grand Island Biologicals (Gibco).
RESULTS
Adenosine deaminase activity in cell free extracts of erythrocytes and lympho-
cyteS:
The patient was studied during his first year of life, prior to and following the transfusion of packed erythrocytes. Determinations of the specific activity of ADA are recorded in Table I . ADA activity of lymphocyte preparations was not affected by the transfusioni it was approximately 15% of normal before and after the administration of packed erythrocytes.
In hemolysates enzyme activity was initially low (1 nmol/mq W/hd, but increased following transfusion. After 10 days it was 28.6 m l / m q W r i it then declined in a logarithmic fashion and reached pretransfusion levels after approximately 4 months.
Adenosine deaminase activity in intact lymphocytes and erythrocytes:
Adenosine metabolism of intact cells was initially carried out when the child was 45 days old, two weeks after he had been transfused with packed erythrocytes. Adenosine deamination in freshly harvested cells incubated in Hanks' solution was measured by following the metelites of 18-14c1 adenosine excreted into the medium. In intact lymphocytes (Table I1 Exp. A) deamination was abnormally low but detectable throughout the course of study. When control lymphocytes were incubated with low concentration (9pM) of adenosine less than 0.28 of radioactivitv in the medium was recovered as adenosine. while over 99% of the radioactivity was in inosine and hypoxanthine. In the medium of the patient's lymphocytes 60-838 of the radioactivity was recovered as adenosine. At high adeMsine concentration (109vM), control lymphocytes metabolized 60% of the substrate while the patient's lymphocytes deaminated 12% of the available adenosine into hypoxanthine and inosine (Table I1 Exp.9).
Impairment of adenosine deamination in the child's intact erythrocytes was initially masked by the transfused donor erythrocytes. Thirty seven days after transfusion, activity in hemolysates was only 158 that of control hemolysates (Table I) . Intact erythrocytes obtained from the patient at that time could metabolize almost all (97 to 99%) of the adenosine (Table 1IExps .cand~). The enzyme deficiency became more readily apparent 106 days after transfusion, when donor cells were no longer present and even low concentrations of adenosine (37 pH) were only partially metabolized and approximately 80 to 908 of the radioactivity in the medium was recovered as adenosine (Table I1 Exp. C). Control erythrocytes deaminated adenosine completely and therefore their deaminating capacity exceeds that measured under these experimental conditions. It is of interest to note that, at 106 days after transfusion, when the ADA-erythrocytes deaminated adenosine poorly (TableIIExps. C and Dl, a small fraction (0.9-3.5%) of [8-14~1 adenosine was metabolized to [8-14c1 adenine. Less than 18 of the radioactive metabolites chromatographed as adenine in ADA' erythrocytes or erythrocytes obtained from the patient 15 and 37 days following transfusion. In ADA deficient lymphocytes the appearance of radioactive adenine in the media was not as consistent (Table I1 Exp. A).
Incorporation of [8-14cl adenosine into lymphocytes and erythrocytes:
The incorporation of 18-14c1 adenosine into acid soluble purine ribonucleotides was measured in renting and PHA stimulated lymphocytes (Table 111) . In resting lymphocytes (Exps. A and 9) adenosine incorporation was no higher in the ADA-than in the control. PHA stimulation for 3 hrs failed to increase adenosine incorporation in either the ADA-or the control cells (Table I11 Exp. B).
In contrast to the findings in ADA-lymphocytes (Table 111) . the incorporation of adenosine into ribonucleotides by erythrocytes obtained from the patient was several fold higher than in control erythrocytes ( Table N) . Surprisingly, as early as 15 days following transfusion, adenosine incorporation of the patient's erythrocytes was high and remained so throughout the study. This difference in incorporation was equally marked at low (Exp. A) and at high (Exp. B) adenosine concentrations.
Incorporation of adenine into ribonucleotides was no higher in the patient's erythrocytes than in the control in studies carried out simultaneously (Table IV Exp. C).
The radiolabelling pattern of ade~sine into adenine and guanine ribonucleotides of resting ADA+ and ADA-lymphocytes was compared 135 days after transfusion. Adenosine incorporation into adenine and guanine nucleotides was similar in ADA deficient and control lymphocytes. In erythrocytes, despite the quantitative difference in adenosine incorporation between the patient and the control, the distribution into adenine and guanine ribonucleotides was similar. Approximately 80% of all ribonucleotides newly synthesized were adenine nucleotides (data not shown).
Comparison of the incokporation [8-14c1 adenosine and I3H1 thymidine into TCA precipitable material during the proliferative response to mitogens also failed to reveal an increase in the incorporation of adenosine relative to that of thymidine in the patient's lymphocytes (Table V) . Although there appears to be an increased ratio of 13H1 thymidine to 18-l4 Cl adenosine in the patient's lymphocytes in response to PHA, this increase was not seen during the response to pokeweed mitogen (PWM) or concanavalin A (Con A).
Phosphoribosylpyrophos~hate (PP-Rib-P) content of lymphocytes and erythrocytes
The average PP-Rib-P content of the patient's ADA-lymphocytes freshly harvested from a Ficoll-hypaque gradient was 28 f 16.7 pml/lo6 cells, that of control lymphocytes was 42 f 8.5 pmol/l0' cells (Table VI) . This difference, between PP-Rib-P content of the patient's and control lymphocytes, was not statistically significant. PP-Rib-P content of washed erythrocytes did not vary in the patient between the 15th and 200th day following transfusion and did not differ significantly from the control.
In order to more closely mimic inn conditions, mutant and control lymphocytes were incubated in the patient's plasma as well as in control plasma (69 min at 37'~ (Table VII Exp. la)). PP-Rib-P content was somewhat, but not significantly, lower when cells were incubated in the patient's plasma. Similarly, PP-Rib-P content of freshly drawn, packed erythrocytes was also determined (Table VII Exp. la) and again PP-Rib-P content of mutant and control erythrocytes was similar. When PP-Rib-P synthesis was stimulated by the addition of 30 mM PO during incubation of erythrocytes in either Hanks' solution or control plash (Table VII Exps . lb, 2 and 3) . PP-Rib-P accumulation was comparable in the mutant and the control erythrocytes.
The effect of adenosine, in concentrations similar to those observed in ADA deficient patients, on cellular PP-Rib-P content was tested. Erythrocytes were incubated with varying concentrations (7 to 700 y M ) of adenosine (Table  VIII) at low (0.8 mM) and high (30 mM) phosphate concentrations in the medium. Adenosine depressed PP-Rib-P content of ADA-and control erythrocytes? this was particularly evident at high (30 mM) phosphate concentrations.
DISCUSSION
The present study provided the first opportunity to investigate adenosine metabolism and PP-Rib-P content of lymphocytes and erythrocytes of an ADA deficient child who had been transfused once, at one m n t h of age, and who has as yet not developed clinical or laboratory evidence of imunodeficiency (3). 111 the patient reported here enzyme deficiency, when measured in lysates of erythrocytes (Table I) In contrast to the patient with SCID the incorporation of 18-l4c1 adenosine into purine ribonucleotides of the patient's lymphocytes was no higher than that of ADA+ lymphocytes, even when lymphocytes were stimulated with PHA for 3 hours. The distribution of radioactivity recovered in adenine and guanine nucleotides was similar in the ADA+ and ADA-lymphocytes in spite of the defect in deamination. In ADA-fibroblasts and in Lesch Nyhan lymphoblasts adenosine incorporation into guanine nucleotides is not decreased suggesting that the deamination of AMP to IMP could contribute not only to the synthesis of guanine ribonucleotides but could also explain the observations that uric acid excretion in ADA deficiency is m t unusually low (20,21,2).
In intact erythrocytes the defect in deamination was also apparent. However the relative degree of deficiency could not be accurately assessed, since ADA+ erythrocytes deaminated adenosine c w l e t e l y even at very high adenosine concentrations in the medium. Adenosine incorporation into ribonucleotides in the patient's erythrocytes was distinctly different from that of lymphocytesj it was significantly higher in the patient's erythrocytes than in the control. This finding was surprising and as yet unexplained because it occurred even when ADA deficiency was attenuated by the presence of donor erythrocytes in the b l w d sample (~ables I~~~I I ) .
While adenosine incorporation into ribanucleotides was high in the patient's erythrocytes, adenine incorporation was not elevated and was similar to that of the control throughout the time of the study (Table IV Exp. C). Most recently the intracellular concentrations of 2'-dATP of the erythrocytes of this patient were measured and found within normal limits while 2'-dATP levels of erythrocytes of patients with SCID were more than 50-fold higher than in control erythrocytes (23).
Adenosine can lower cellular PP-Rib-P content and therebv wssiblv imair lymphocyte proliferation (17.22). So far PP-Rib-P content of-ekythrocytes-and lymphocytes of ADA deficient patients with SCID have not been reported. In our patient's lymphocytes the cellular PP-Rib-P content was not statistically different from that of the control nor was the PP-Rib-P content of his erythrocytes abnormally low even though they lacked ADA activity (Table VII) . Incubation of erythrocytes with 30 mM PO , which stimulates PP-Rib-P synthesis provided further p r m f that ADA deficiett erythrocytes unlike purine nucleoside phosphorylase deficient erythrocytes do not accumulate excessive amunts of PP-Rib-P (Tables VII and VIII) 
(4).
This study of purine and PP-Rib-P metabolism of lymphocytes and erythrocytes of an ADA deficient child, in whom cellular and humoral immune functions were not impaired, shows that some but not all of the biochemical abnormalities found in children with SCID were present (3,12,4) . In contrast to patients with SCID we found no increase in the incorporation of 18-14c1 adenosine into ribonucleotides of lymphocytes and only partial impairment of adenosine deamination in intact lymphocytes. This latter observation correlates with the findings in lymphocyte lysates of this patient (Table I) (3,12) . Although these findings may explain why this ADA deficient child and the children in the 1Kung tribe remain immunocompetent, there may be other as yet unrecognized mechanisms which are important for the integrity of immune function. Erythrocytes were harvested from freshly drawn heparinized blood by centrifugation for 1 min in a microcentrifuge. PP-Rib-P content was measured immediately on unwashed cells (no incubation) and after incubation for 60 min in 1 m1 Hanks' solution or plasma with the additions as noted. Lymphocytes (1.5-3 x 1 0 cells) were incubated in 1 m l plasma. All incubations were carried out in air at 37' and determinations performed in duplicate. PP-Rib-P content was determined immediately as described in Materials and Methods. 
EFFECT OF ADENOSINE OF PP-RIB-P CONTENT OF ADA-AND
